REFERENCES
- Andronis V., Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Cryst. Solids 2000; 271: 236–248
- Avramova N., Fakirov S. Study of the healing process in native cellulose. Macromol. Chem., Rapid Commun. 1990; 11: 7–10
- Bogdanova S., Avramova N. Indomethacin/carriers interactions in formation of sorbates—effects on drug polymorphism (pp. 157–158). Proceedings—3rd World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, Berlin, April 3–6, 2000
- Bogdanova S., Ford J. Polymorphic transitions of indomethacin in the preparation of indomethacin-haemodex sorbates. STP Pharma. Sci. 1998; 8: 85–90
- Bogdanova S., Pajeva I., Nikolova P., Tsakovska I., Mueller B. Interactions of poly(vinylpyrrolidone) with ibuprofen and naproxen: Experimental and modeling studies. Pharm. Res. 2005; 22: 806–815
- Chiou W., Riegelman S. Pharmaceutical application of solid dispersion systems. J. Pharm. Sci. 1971; 60: 1281–1302
- Hancock B., Parks M. What is the True Solubility Advantage for Amorphous pharmaceuticals?. Pharm. Res. 2000; 17: 397–404
- Lee J., Park J., Robinson J. Bioadhesive-based dosage forms: The next generation. J. Pharm. Sci. 2000; 89: 850–866
- Legendre B., Feutelais Y. Polymorphic and thermodynamic study of indomethacin. J. Therm. Anal. Calorim. 2004; 76: 255–264
- Matsumoto T., Zografi G. Physical properties of solid molecular dispersion of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm. Res. 1999; 16: 1722–1728
- http://www.pharmscitech.org Otsuka, M., Kato, F., Matsuda, Y., & Ozaki, Y. (2003). Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry. AAPS Pharm. Sci. Tech., 4(2), Article 19
- Taylor L., Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 1997; 14: 1691–1698
- Tong P., Zografi G. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid. Pharm. Res. 1999; 16: 1186–1192
- Valizadeh H., Nokhodchi A., Qarakhani N., Zakeri-Milani P., Azarmi S., Hassanzadeh D., Loebenberg R. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin and Eudragit® E100. Drug Dev. & Ind. Pharm. 2004; 30: 303–317
- Yoshioka M., Hancock B., Zografi G. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J. Pharm. Sci. 1995; 84: 963–986